APVO
Aptevo Therapeutics Inc
NASDAQ: APVO · HEALTHCARE · BIOTECHNOLOGY
$1.30
+1.56% today
Updated 2026-10-28
Market cap
$2.93M
P/E ratio
0.02
P/S ratio
2.70x
EPS (TTM)
$66.96
Dividend yield
—
52W range
$1 – $29
Volume
0.1M
Aptevo Therapeutics Inc (APVO) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$1.30
12-Month target
$52,755.76
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 0.02x (capped 25x) · Margin: 0.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.